Correlation Between Lyra Therapeutics and Affimed NV

Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Affimed NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Affimed NV into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lyra Therapeutics and Affimed NV, you can compare the effects of market volatilities on Lyra Therapeutics and Affimed NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Affimed NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Affimed NV.

Diversification Opportunities for Lyra Therapeutics and Affimed NV

0.17

Correlation Coefficient

Lyra Therapeutics  Affimed NV

Average diversification

The 3 months correlation between Lyra and Affimed is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Affimed NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Affimed NV and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Affimed NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Affimed NV has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Affimed NV go up and down completely randomly.

Pair Corralation between Lyra Therapeutics and Affimed NV

Given the investment horizon of 90 days Lyra Therapeutics is expected to generate 0.76 times more return on investment than Affimed NV. However, Lyra Therapeutics is 1.31 times less risky than Affimed NV. It trades about 0.02 of its potential returns per unit of risk. Affimed NV is currently generating about -0.26 per unit of risk. If you would invest  21.00  in Lyra Therapeutics on December 2, 2024 and sell it today you would earn a total of  0.00  from holding Lyra Therapeutics or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lyra Therapeutics  vs.  Affimed NV

Lyra Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Lyra Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Lyra Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Affimed NV

Risk-Adjusted Performance

Very Weak

Over the last 90 days Affimed NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Lyra Therapeutics and Affimed NV

The main advantage of trading using opposite Lyra Therapeutics and Affimed NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Affimed NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Affimed NV will offset losses from the drop in Affimed NV's long position.

The idea behind Lyra Therapeutics and Affimed NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.